Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.
Qualisteo, is a company based in Nice (France) specialized in energy efficiency for industrial and tertiary sites
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
INNOVO by Atlantic Therapeutics is a medical technology firm that develops pelvic floor muscle strengthening and nerve stimulation products.
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system.
Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
Lhyfe is a producer and supplier of green hydrogen, generated through renewable energy sources.
EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
Qovoltis offers smart charging solutions for electric vehicles and a mobile app for remote management.
Skysun is a financial institution that provides financial solutions and services to the solar energy sector.
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
Andera Partners has invested in 65 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Andera Partners's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Medical Device. The firm invests across 28 different industry categories.
Among tracked funding rounds, Tubulis received $400.6M in a Series C round. Andera Partners's total known invested capital is $5.3B.
Andera Partners's average investment size is $81.9M across its portfolio of 65 companies.
Recent Andera Partners portfolio additions include Inotrem, Qualisteo, Dualyx, Ariceum Therapeutics, Amolyt Pharma. These companies were founded in 2020 or later.